Atb Cap Markets Expects Lower Earnings for Canopy Growth

Canopy Growth Co. (NASDAQ:CGC) – Investment analysts at Atb Cap Markets reduced their Q3 2025 earnings per share estimates for shares of Canopy Growth in a research note issued on Sunday, November 10th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of ($0.49) for the quarter, down from their previous estimate of ($0.35). The consensus estimate for Canopy Growth’s current full-year earnings is ($2.08) per share. Atb Cap Markets also issued estimates for Canopy Growth’s Q4 2025 earnings at ($0.40) EPS, FY2026 earnings at ($1.35) EPS, FY2027 earnings at ($2.71) EPS, FY2028 earnings at ($15.47) EPS and FY2029 earnings at ($7.20) EPS.

Canopy Growth Trading Down 5.1 %

CGC opened at $3.74 on Wednesday. The company has a quick ratio of 1.64, a current ratio of 1.39 and a debt-to-equity ratio of 0.82. Canopy Growth has a 52 week low of $2.76 and a 52 week high of $14.92. The stock has a market cap of $351.05 million, a PE ratio of -0.76 and a beta of 0.87. The business has a 50 day moving average of $4.60 and a 200-day moving average of $6.52.

Hedge Funds Weigh In On Canopy Growth

Large investors have recently modified their holdings of the stock. PFG Investments LLC bought a new stake in Canopy Growth in the 3rd quarter worth about $54,000. Financial Advocates Investment Management bought a new stake in shares of Canopy Growth in the third quarter worth approximately $57,000. CIBC Asset Management Inc purchased a new position in shares of Canopy Growth during the second quarter valued at approximately $91,000. Insigneo Advisory Services LLC bought a new position in Canopy Growth during the second quarter valued at approximately $96,000. Finally, Genesee Capital Advisors LLC boosted its holdings in Canopy Growth by 15.3% in the second quarter. Genesee Capital Advisors LLC now owns 15,047 shares of the company’s stock worth $97,000 after purchasing an additional 2,000 shares during the last quarter. Hedge funds and other institutional investors own 3.33% of the company’s stock.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.